Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PAAD | rs36055753 | chr1:227464748 | C/T | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
PAAD | rs36160442 | chr16:8739822 | C/T | 0.000157 | 178 | 4.93 | 15.5 | 15.6 | KM Plot |
PAAD | rs363411 | chr10:119013632 | A/G | 0.000105 | 178 | 40.53 | 11.77 | 16.05 | KM Plot |
PAAD | rs367709210 | chr1:227431702 | CA/C | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
PAAD | rs367864336 | chr11:125732632 | G/A | 0.000114 | 175 | 15.87 | 12.2 | 4.1 | KM Plot |
PAAD | rs368380515 | chr11:125732294 | G/A | 0.000114 | 175 | 15.87 | 12.2 | 4.1 | KM Plot |
PAAD | rs369937731 | chr2:70499827 | CATTT/C | 0 | 178 | 15.37 | 17.4 | 1.03 | KM Plot |
PAAD | rs370191769 | chr1:227297927 | CTCTT/C | 3.2E-5 | 178 | 15.53 | 15.65 | 3.9 | KM Plot |
PAAD | rs370411410 | chr7:102831450 | TATC/T | 4.77E-10 | 170 | 16.28 | 11.98 | 4.1 | KM Plot |
PAAD | rs370763511 | chr1:16314467 | CTG/C | 2.03E-6 | 176 | 3.43 | 14 | 15.62 | KM Plot |
PAAD | rs370788119 | chr1:227290669 | TA/T | 3.2E-5 | 178 | 15.53 | 15.65 | 3.9 | KM Plot |
PAAD | rs371144525 | chr1:227463291 | TC/T | 3.22E-5 | 178 | 15.55 | 15.43 | 3.9 | KM Plot |
PAAD | rs371269425 | chr7:102588235 | T/TA | 3.86E-8 | 174 | 16.28 | 12.63 | 3.43 | KM Plot |
PAAD | rs371764045 | chr11:125574236 | TAC/T | 0.000112 | 177 | 16.08 | 14.18 | 5.03 | KM Plot |
PAAD | rs372393390 | chr7:44332655 | GC/G | 0 | 170 | 15.57 | 13.47 | 2.68 | KM Plot |